Phase 4
N=68
Comparison of Bacteriostatic Saline to Buffered Lidocaine for Ultrasound Guided Hip Joint Injection Local Anesthesia
Hip Pain
Bottom Line
View on ClinicalTrials.gov: NCT02209272 ↗Enrolled (actual)
68
Serious AEs
0.0%
Results posted
Apr 2019
Primary outcome: Primary: VAS for Pain Score During Local Anesthesia Infiltration — 13.2; 14 score on a scale — p=0.82
Study Design & Population
- Study type
- Interventional
- Phase
- Phase 4
- Interventions
- bacteriostatic saline (Drug); buffered lidocaine (Drug)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Mayo Clinic
- Primary completion
- Feb 2018
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY VAS for Pain Score During Local Anesthesia Infiltration |
13.2; 14 | 0.82 |
| SECONDARY VAS for Pain Score During Subsequent Hip Joint Injection (Local Anesthetic Efficacy) |
20.7; 15.6 | 0.21 |
| SECONDARY Anesthetic Infiltration Duration |
33.3; 32.7 | 0.57 |
Summary
The purpose of this study is to compare infiltration pain and anesthetic efficacy between lidocaine and Bacteriostatic saline (BS) for ultrasound (US) guided intraarticular hip injections.
Eligibility Criteria
INCLUSION CRITERIA
- age 18-75 years
- referred for US-guided intraarticular hip injections in the Mayo Clinic Sports Medicine Center, Physical Medicine & Rehabilitation Clinic, or Musculoskeletal Clinic
EXCLUSION CRITERIA
- chronic opioid use
- opioid use on day of procedure
- history of fibromyalgia or other diffuse chronic pain syndrome
- pain behavior during the clinical encounter as judged by the injectionist
- anesthetic administration time outside the designated 5-15 second time frame
Data sourced from ClinicalTrials.gov (NCT02209272). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.